Our Solution

Two ways to extract value
from in silico predictions

In silico predictions carry inherent uncertainty. The key is knowing how to use them effectively. Toxometris is designed for both use cases.

Use Case 1

Mechanistic interpretation of predictions

When working with a limited number of compounds, the most value comes from understanding why a prediction was made — not just what the prediction is.

For each compound, our reports include read-across analysis comparing your molecule to the three most structurally similar compounds with known experimental values, plus structural alert analysis for genotoxicity endpoints.

Understand the structural basis of each prediction
Read-across: 3 closest analogues with known experimental data
Structural alerts highlighted for genotoxicity endpoints
Actionable guidance for compound optimisation
Reports suitable for regulatory dossiers
Best for

Lead optimisation

Understand which structural features drive toxicity flags and iterate intelligently.

Regulatory submission support

Get OECD-compliant predictions with mechanistic narrative ready for inclusion in safety dossiers.

Expert report add-on

Combine automated predictions with written interpretation from medicinal chemists and toxicologists.

Risk Score: 0 → 1
Most promising0.1
Low risk0.3
Moderate concern0.6
High risk — deprioritise0.8
Likely rejected0.95

Lower score = higher likelihood of pharmaceutical acceptance

Use Case 2

Risk Score bulk screening

When working with hundreds or thousands of compounds, reviewing every endpoint for every molecule is impossible. The Risk Score collapses your entire ADMET profile into a single number.

Submit your full compound library. The Risk Score ranks every compound by its likelihood of acceptance as a pharmaceutical — so your team can focus resources on the most promising candidates.

Screen thousands of compounds in minutes
Single composite score based on all ADMET endpoints
Rank compounds 0–1 by pharmaceutical acceptance likelihood
Identify and deprioritise high-risk compounds early
Supports large-scale virtual screening campaigns
Our Technology

Consensus models across multiple molecular representations

Advanced algorithms with mechanistic interpretability — not a trade-off between performance and transparency, but both.

Graph Neural Networks

GNNs applied to molecular graphs, learning directly from atom and bond connectivity — the most information-rich representation.

Large Language Models

LLMs applied to molecular SMILES strings, capturing chemical language patterns learned from large-scale training data. Used for a subset of endpoints where sequence-based representations yield strong predictive performance.

Consensus Modelling

Predictions combined across SMILES, fingerprints, graphs, and descriptors — reducing noise, bias, and variance of any single model.

OECD-Aligned Validation

Every model follows OECD Principles 1–5: defined endpoint, unambiguous algorithm, applicability domain, goodness-of-fit metrics, and mechanistic interpretation.

Mechanistic Transparency

Structural alerts and read-across methods ensure users understand the evidence behind each prediction — essential for regulatory confidence.

Continuous Cloud Updates

Models are updated as new training data becomes available. Your subscription always accesses the latest, most accurate versions.

See it in action with your own compounds.

Free trial — 2 compounds, no credit card required.